↓ Skip to main content

Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma

Overview of attention for article published in Frontiers in immunology, June 2024
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
1 Mendeley